000 01496 a2200457 4500
005 20250513090545.0
264 0 _c19960626
008 199606s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHo, P T
245 0 0 _aA prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
_h[electronic resource]
260 _bCancer
_cDec 1995
300 _a2557-64 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents, Alkylating
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadverse effects
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aMale
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aSarcoma
_xdrug therapy
650 0 4 _abeta 2-Microglobulin
_xurine
700 1 _aZimmerman, K
700 1 _aWexler, L H
700 1 _aBlaney, S
700 1 _aJarosinski, P
700 1 _aWeaver-McClure, L
700 1 _aIzraeli, S
700 1 _aBalis, F M
773 0 _tCancer
_gvol. 76
_gno. 12
_gp. 2557-64
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9
_zAvailable from publisher's website
999 _c8624130
_d8624130